Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)

PHASE3RecruitingINTERVENTIONAL
Enrollment

4,674

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2026

Conditions
Ischemic Stroke, AcuteTIASymptomatic Intracranial Artery Stenosis
Interventions
DRUG

Tirofiban

Initial infusion of tirofiban 0.4μg/kg body weight/minute for 30 minutes (a maximum dose of 1mg) within 24 hours of symptom onset, followed by a continuous infusion of tirofiban 0.1μg/kg body weight/minute for 48 hours.

DRUG

Placebo

Initial infusion of saline placebo for 30 minutes within 24 hours of symptom onset, followed by a continuous infusion of placebo for 48 hours.

Trial Locations (5)

150086

RECRUITING

The 2nd Affiliated Hospital of Harbin Medical University, Harbin

251199

RECRUITING

People's Hospital of Qihe County, Dezhou

252001

RECRUITING

Liaocheng People's Hospital(Liaocheng Brain Hospital), Liaocheng

252004

RECRUITING

Third People's Hospital of Liaocheng, Liaocheng

265699

RECRUITING

Yantai Penglai traditional Chinese medicine hospital, Yantai

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER